Life-Sciences-Germany.com
The Life Sciences Web Portal for German-speaking Europe

This is a free web portal for the life sciences in German-speaking Europe... » read more

Healx Ltd Secures $56m Series B Round Led by Atomico (2019-10-16)
Latest round of funding, led by Atomico, will be used to build a clinical-stage portfolio for rare diseases, including treatments for fragile X syndrome, the leading genetic cause of autism. Healx’s Rare Treatment Accelerator programme is a new initiative launched ...
Abalos Therapeutics Launches with €12M Series A Round (2019-10-15)
-- Dr. Marcus Kostka appointed CEO, Dr. Jörg Vollmer joins as CSO -- Abalos Therapeutics announced today a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutic...
CRISPR Therapeutics & KSQ Therapeutics: License Agreement (2019-10-15)
- CRISPR Therapeutics to receive non-exclusive access to certain KSQ IP for its allogeneic CAR-T programs - - KSQ Therapeutics to receive non-exclusive access to certain CRISPR IP for its autologous cell therapies, including its existing eTIL™ cell franchise - ...
Numab Appoints Daniel Vasella to Board of Directors (2019-10-15)
Numab Therapeutics AG today announced that effective October 1 it has appointed former Novartis CEO and Chairman Dr. Daniel Vasella to its Board of Directors. Dr. David Urech, CEO of Numab, said: “We are delighted to welcome Daniel Vasella to our Board of Dir...
BioNtech Prices $150m US IPO at Nasdaq at $15 per ADS (2019-10-10)
BioNTech SE (“BioNTech”), a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, today announced the pricing of its initial public offering of 10,000,000 American Depositary Shares ...
Bayer Launches LifeHub UK Focused on AI-based Drug Discovery (2019-10-10)
Collaborations with external partners will drive development of AI-enabled radiology to enhance patient outcomes / LifeHub UK is the newest member of Bayer’s network of LifeHubs designed to plug into the global innovation ecosystems to solve challenges in health an...
Biocon Licenses Pre-clinical Biosimilar from Just-Evotec (2019-10-10)
> BIOCON BIOLOGICS IN-LICENSES AN EARLY-STAGE BIOSIMILAR ASSET, WILL UNDERTAKE DEVELOPMENT, MANUFACTURING AND COMMERCIALISATION UNDER ITS OWN LABEL > JUST - EVOTEC BIOLOGICS HAS RECEIVED A LICENSE FEE AND WILL RECEIVE MILESTONE PAYMENTS Evotec SE (Frankfurt...
GSK & Lyell Immunopharma to Develop Cancer Cell Therapies (2019-10-08)
Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability GlaxoSmithKline plc today announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new tech...
Bayer & RIKEN Innovation: Strategic Drug Discovery Alliance (2019-10-08)
> New collaboration to explore novel drug discovery targets across indications and identify joint research projects > Synergizing RIKEN’s excellence in basic research with Bayer’s expertise in global drug discovery Bayer AG (Bayer), and RIKEN Innovation ...
Illumina & Qiagen Partner for Sequencing-based IVD Tests (2019-10-07)
Partnership to accelerate the adoption of next-generation sequencing (NGS) in clinical decision-making Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) today announced a 15-year partnership intended to broaden the avai...

» Show all News!"

Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!

[LSG] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Germany, Austria and Switzerland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!

Start here with the latest News!

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)